Open Access
05.05.2024 | Correction
Correction: Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
verfasst von:
Kerstin Wimmer, Dominik Hlauschek, Marija Balic, Georg Pfeiler, Richard Greil, Christian F. Singer, Stefan Halper, Günther Steger, Christoph Suppan, Simon P. Gampenrieder, Ruth Helfgott, Daniel Egle, Martin Filipits, Raimund Jakesz, Lidija Sölkner, Christian Fesl, Michael Gnant, Florian Fitzal
Erschienen in:
Breast Cancer Research and Treatment
|
Ausgabe 2/2024
In this article, the order that the author Richard Greil appeared in the author list was incorrect and below two minor errors were missed out by mistake.
1.
In Methods under Abstract “0a6A” should have read “06a”
2.
In the last line of Introduction “-06A” trial should have read “06a”
The original article has been corrected.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit
http://creativecommons.org/licenses/by/4.0/.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.